Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
23.83
+0.23 (0.97%)
At close: Apr 17, 2025, 4:00 PM
23.99
+0.16 (0.67%)
After-hours: Apr 17, 2025, 7:46 PM EDT

Viking Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2,6874,4841,862721360411
Upgrade
Market Cap Growth
140.89%140.89%158.23%100.31%-12.38%-29.13%
Upgrade
Enterprise Value
1,7863,5551,487567144156
Upgrade
Last Close Price
23.9440.2418.619.404.605.63
Upgrade
PB Ratio
3.035.095.344.961.781.68
Upgrade
P/TBV Ratio
3.055.095.344.961.781.68
Upgrade
Debt / Equity Ratio
0.000.000.000.0100.00
Upgrade
Quick Ratio
32.9332.9318.927.0923.0220.48
Upgrade
Current Ratio
33.0933.0919.197.6123.9821.12
Upgrade
Return on Equity (ROE)
-17.90%-17.90%-34.79%-39.67%-24.65%-15.15%
Upgrade
Return on Assets (ROA)
-14.77%-14.77%-23.47%-23.19%-14.90%-9.86%
Upgrade
Return on Capital (ROIC)
-15.32%-15.32%-25.38%-25.21%-15.58%-10.21%
Upgrade
Earnings Yield
-409.21%-2.45%-4.61%-9.55%-15.28%-9.62%
Upgrade
Buyback Yield / Dilution
-1557.00%-15.57%-22.79%0.47%-6.34%-0.89%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q